顺铂加同期放疗治疗中晚期食管癌疗效分析

THE CONCURENT TREATMENT OF ADVANCED ESOPHAGEAL CANCER BY REDIOTHERAPY AND CIS-PLATINUM

目的 评价顺铂增敏放射治疗食管癌的疗效及并发症.方法 对30例中晚期食管癌进行顺铂(DDP)增敏的放射治疗并与同期的单纯放射治疗的食管癌30例进行疗效比较.DDP 20mg每周五次.放疗均用10Mev X线等中心治疗,剂量60 Gy～70 Gy/6～7 wk.结果 一、三、五年生存率分别为单纯放射组46.7%、20%、10%;放化疗组60%、30%、23%.结论 DDP增敏的放射治疗能提高食管癌的近期和远期疗效,且无严重的并发症.

PURPOSETo evaluate the radiosensitizing effect of cisplatin combined with radiotherapy for esophageal carcinoma. METHODS From 1989 to 1990. 60 patients with esophageal were treated. It was divided into two groups. Radiotherapy group (R) and radiotherapy plus cisplatin (20mg iv. twice a week) (R + C). A total dose of 66-70 Gy/6-7 wk was used in (R) and (R+C) group. RESULTS The 1 year. 3 year. 5 year survival rats were R : R+C = 46. 7%、20%、10% : 60%、30%、23%. CONCLUSION This study may imply that rational administration of cisplatin in the radiotherapy could improve the radiotherapy result of the esophageal carcinoma.